In October 2026, Illumina announced SpliceAI2, a new genomic AI model that helps researchers better identify disease-relevant ...
Illumina, Inc. (NASDAQ: ILMN) today introduced SpliceAI2, a new genomic AI model designed to address one of the central challenges in genomics: understanding the functional consequences of genetic ...
A newly published study identifies the VEGF-A splice variant VEGF165b as an endogenous protector that shields the lung's ...
The list of tools includes SpliceA12, a new iteration of a genomic AI model designed to identify disease-relevant splice ...
Illumina introduced SpliceAI2 on October 8, 2026, a genomic AI model from its BioInsight AI Lab that predicts how genetic ...
Tim Richardson (left) is a software engineer at Genomics England (London, UK), with a particular interest in the use of AI to help understand biology and the evaluation of these tools against ...
Newswise — Researchers from Chinese Academy of Medical Sciences and Peking Union Medical College, et al. have conducted a study entitled “High frequency of alternative splicing variants of the ...
Illumina, Inc. introduced SpliceAI2, a new genomic AI model designed to address one of the central challenges in genomics: understanding the functional consequences of genetic variation. SpliceAI2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results